Haplotype analysis revealed a genetic influence of osteopontin on large artery atherosclerosis

Journal of Biomedical Science

Volumn 15, Issue 4, 2008, Pages 529-533

  Kim, Younyoung ^a   Lee, Chaeyoung ^a  

^a Hallym University   (South Korea)

Author keywords

Genetic polymorphism; Ischemic stroke; Risk factor

Indexed keywords

OSTEOPONTIN;

ARTICLE; BLOOD VESSEL OCCLUSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DNA ISOLATION; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTERIES; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 44949241652     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-008-9240-4     Document Type: Article

References (11)

1. Strom A, Franzen A, Wangnerud C, Knutsson AK, Heinegard D, Hultgardh-Nilsson A (2004) Altered vascular remodeling in osteopontin-deficient atherosclerotic mice. J Vasc Res 41:314-322
2. Wang X, Louden C, Yue TL, Ellison JA, Barone FC, Solleveld HA, Feuerstein GZ (1998) Delayed expression of osteopontin after focal stroke in the rat. J Neurosci 18:2075-2083
3. Brenner D, Labreuche J, Touboul PJ, Schmidt-Petersen K, Poirier O, Perret C, Schonfelder J, Combadiere C, Lathrop M, Cambien F, Brand-Herrmann SM, Amerenco P (2006) Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients. Stroke 37:1691-1696
4. Kim Y, Lee C (2006) The gene encoding transforming growth factor β1 confers risk of ischemic stroke and vascular dementia. Stroke 37:2843-2845
5. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
6. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C (1993) Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 13:120-125
7. Gravallese EM (2003) Osteopontin: a bridge between bone and the immune system. J Clin Invest 112:147-149
8. Matsui Y, Rittling SR, Okamoto H, Inobe M, Jia N, Shimizu T, Akino M, Sugawara T, Morimoto J, Kimura C, Kon S, Denhardt D, Kitabatake A, Uede T (2003) Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23:1029-1034
9. Di Paola R, Frittitta L, Miscio G, Bozzali M, Baratta R, Centra M, Spampinato D, Santagati MG, Ercolino T, Cisternino C, Soccio T, Mastroianno S, Tassi V, Almgren P, Pizzuti A, Vigneri R, Trischitta V (2002) A variation in 3′ UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 70:806-812
10. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, Sadée W (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104:20552-20557
11. Komar AA (2007) Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 8:1075-1080